Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Collaborate with Procter & Gamble on GeneExpress

NEW YORK, Dec 22 - Gene Logic and Procter & Gamble have forged an extended
collaboration agreement, the companies announced Friday. Gene Logic will build a custom database that combines the pharmaceutical company's proprietary data with the gene expression information in Gene Logic's GeneExpress suite of databases, and
Proctor & Gamble will provide Gene Logic with normal and diseased human heart tissue for inclusion in GeneExpress.

Under the agreement, Proctor & Gamble will also become a subscriber to GeneExpress, gaining access to the Atlas DataSuite, which provides gene expression data for normal human tissue. Gene Logic will integrate the GeneExpress and Proctor & Gamble data using its GX2000 data mining and analysis software.

" We expect that access to the GeneExpress data in combination with our proprietary data will improve the speed and efficiency with which we identify and validate novel drug targets across our therapeutic focus areas," Gordon Hassing, vice president of R&D and global pharmaceuticals for P&G, said in a statement.

The companies did not disclose the financial terms of the agreement.

This collaboration is part of Gene Logic and Proctor & Gamble's ongoing collaboration to better characterize the genetic expression involved in heart disease and osteoporosis.

" The opportunity to acquire important clinical data regarding these critical disease areas will enhance our ability to deliver viable solutions for our pharmaceutical and biotechnology customers." David Murray, Gene Logic's senior vice president of marketing, said in a statement. " This collaboration extension is mutually beneficial for not only P&G and Gene Logic but, more importantly, our current and prospective GeneExpress subscribers as well."

This announcement comes on the heels of Gene Logic's announcement Thursday that it had signed on as subscribers Organon and Boehringer Ingelheim Pharmaceuticals, and had penned a custom database agreement with Biogen.

With these new deals and the Proctor & Gamble subscription, GeneLogic now has eleven subscribers to GeneExpress.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.